Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases

Allegra Battistoni, Speranza Rubattu, Massimo Volpe

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

The search for molecules that may contribute to better identify patients at risk for cardiovascular diseases (CVD) represents today an active field in clinical research. Few biomarkers have already been identified as reliable and useful tools in medical decision making, such as cardiac troponin (cTn) and NT-proBNP. At the same time, evidence regarding the possible role of other molecules is piling up. Every new putative biomarker has demonstrated effectiveness in at least one clinical application: cardiovascular risk assessment, diagnosis or outcome prediction. On the other hand, combination of preventive, diagnostic and prognostic implications for the same molecule is expected to improve enormously the usefulness of a biomarker in medicine. We performed a search of the literature looking for circulating molecules found to exert discriminating abilities in all three mentioned clinical applications. The purpose of the present review is to bring to the attention of medical and research communities those biomarkers for which a relevant amount of evidence has been accumulated regarding their potential application in all clinical steps of the cardiovascular continuum. Furthermore, since simultaneous testing of different plasmatic molecules has been proposed as a suitable tool to improve medical decision making, we also discuss feasible associations of biomarkers that promise to be the most effective for cardiovascular risk assessment in the general population and for outcome prediction in patients affected by acute coronary syndrome (ACS) and by heart failure (HF).

Original languageEnglish
Pages (from-to)160-168
Number of pages9
JournalInternational Journal of Cardiology
Volume157
Issue number2
DOIs
Publication statusPublished - May 31 2012

Fingerprint

Cardiovascular Diseases
Biomarkers
Troponin
Acute Coronary Syndrome
Biomedical Research
Heart Failure
Medicine
Research
Population
Clinical Decision-Making

Keywords

  • Cardiovascular risk
  • Circulating biomarkers
  • CRP
  • Cystatin-C
  • Interleukines
  • Natriuretic peptides

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. / Battistoni, Allegra; Rubattu, Speranza; Volpe, Massimo.

In: International Journal of Cardiology, Vol. 157, No. 2, 31.05.2012, p. 160-168.

Research output: Contribution to journalArticle

@article{b7e1f944437a4b019ce0693a0de11a11,
title = "Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases",
abstract = "The search for molecules that may contribute to better identify patients at risk for cardiovascular diseases (CVD) represents today an active field in clinical research. Few biomarkers have already been identified as reliable and useful tools in medical decision making, such as cardiac troponin (cTn) and NT-proBNP. At the same time, evidence regarding the possible role of other molecules is piling up. Every new putative biomarker has demonstrated effectiveness in at least one clinical application: cardiovascular risk assessment, diagnosis or outcome prediction. On the other hand, combination of preventive, diagnostic and prognostic implications for the same molecule is expected to improve enormously the usefulness of a biomarker in medicine. We performed a search of the literature looking for circulating molecules found to exert discriminating abilities in all three mentioned clinical applications. The purpose of the present review is to bring to the attention of medical and research communities those biomarkers for which a relevant amount of evidence has been accumulated regarding their potential application in all clinical steps of the cardiovascular continuum. Furthermore, since simultaneous testing of different plasmatic molecules has been proposed as a suitable tool to improve medical decision making, we also discuss feasible associations of biomarkers that promise to be the most effective for cardiovascular risk assessment in the general population and for outcome prediction in patients affected by acute coronary syndrome (ACS) and by heart failure (HF).",
keywords = "Cardiovascular risk, Circulating biomarkers, CRP, Cystatin-C, Interleukines, Natriuretic peptides",
author = "Allegra Battistoni and Speranza Rubattu and Massimo Volpe",
year = "2012",
month = "5",
day = "31",
doi = "10.1016/j.ijcard.2011.06.066",
language = "English",
volume = "157",
pages = "160--168",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases

AU - Battistoni, Allegra

AU - Rubattu, Speranza

AU - Volpe, Massimo

PY - 2012/5/31

Y1 - 2012/5/31

N2 - The search for molecules that may contribute to better identify patients at risk for cardiovascular diseases (CVD) represents today an active field in clinical research. Few biomarkers have already been identified as reliable and useful tools in medical decision making, such as cardiac troponin (cTn) and NT-proBNP. At the same time, evidence regarding the possible role of other molecules is piling up. Every new putative biomarker has demonstrated effectiveness in at least one clinical application: cardiovascular risk assessment, diagnosis or outcome prediction. On the other hand, combination of preventive, diagnostic and prognostic implications for the same molecule is expected to improve enormously the usefulness of a biomarker in medicine. We performed a search of the literature looking for circulating molecules found to exert discriminating abilities in all three mentioned clinical applications. The purpose of the present review is to bring to the attention of medical and research communities those biomarkers for which a relevant amount of evidence has been accumulated regarding their potential application in all clinical steps of the cardiovascular continuum. Furthermore, since simultaneous testing of different plasmatic molecules has been proposed as a suitable tool to improve medical decision making, we also discuss feasible associations of biomarkers that promise to be the most effective for cardiovascular risk assessment in the general population and for outcome prediction in patients affected by acute coronary syndrome (ACS) and by heart failure (HF).

AB - The search for molecules that may contribute to better identify patients at risk for cardiovascular diseases (CVD) represents today an active field in clinical research. Few biomarkers have already been identified as reliable and useful tools in medical decision making, such as cardiac troponin (cTn) and NT-proBNP. At the same time, evidence regarding the possible role of other molecules is piling up. Every new putative biomarker has demonstrated effectiveness in at least one clinical application: cardiovascular risk assessment, diagnosis or outcome prediction. On the other hand, combination of preventive, diagnostic and prognostic implications for the same molecule is expected to improve enormously the usefulness of a biomarker in medicine. We performed a search of the literature looking for circulating molecules found to exert discriminating abilities in all three mentioned clinical applications. The purpose of the present review is to bring to the attention of medical and research communities those biomarkers for which a relevant amount of evidence has been accumulated regarding their potential application in all clinical steps of the cardiovascular continuum. Furthermore, since simultaneous testing of different plasmatic molecules has been proposed as a suitable tool to improve medical decision making, we also discuss feasible associations of biomarkers that promise to be the most effective for cardiovascular risk assessment in the general population and for outcome prediction in patients affected by acute coronary syndrome (ACS) and by heart failure (HF).

KW - Cardiovascular risk

KW - Circulating biomarkers

KW - CRP

KW - Cystatin-C

KW - Interleukines

KW - Natriuretic peptides

UR - http://www.scopus.com/inward/record.url?scp=84861095172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861095172&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2011.06.066

DO - 10.1016/j.ijcard.2011.06.066

M3 - Article

C2 - 21763018

AN - SCOPUS:84861095172

VL - 157

SP - 160

EP - 168

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 2

ER -